Similarly, Rodriguez et al showed that B16 melanoma cell lines stably expressing NLRC5 re‐established MHC‐I antigen presentation and induced the activation and proliferation of Pmel‐1 TCR transgenic CD8+ T‐cells in response to endogenous tumour antigen. This evidence concerns the gene NLRC5 and melanoma.